Clinical Trials Logo

Filter by:
NCT ID: NCT01321554 Completed - Thyroid Cancer Clinical Trials

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Trial of Lenvatinib (E7080) in 131I-Refractory Differentiated Thyroid Cancer (DTC)

SELECT
Start date: March 17, 2011
Phase: Phase 3
Study type: Interventional

This is a multicenter, randomized, double-blind, placebo-controlled Phase 3 study to compare the progression free survival, overall response rate (ORR) and safety of participants treated with lenvatinib 24 mg by continuous once daily oral dosing versus placebo. The study is conducted in 3 phases: a Prerandomization Phase (screening and baseline period), a Randomization Phase (double-blind treatment period), and an Extension Phase (Optional Open Label (OOL) Lenvatinib Treatment Period and a follow-up period).

NCT ID: NCT01321489 Not yet recruiting - Clinical trials for Erectile Dysfunction

A Study to Evaluate a Possible Superiority Expressed by the Faster Onset of Action and the Efficacy and Safety of Sildenafil Citrate 20mg Sublingual Tablet in the Treatment of Erectile Dysfunction of Different Etiologies

Start date: September 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the tolerability and safety of Sildenafil Citrate 20mg Sublingual tablet, as well as a possible superiority expressed by the faster onset of action compared to Viagra ® 50mg tablet Coated in erectile dysfunction.

NCT ID: NCT01321268 Terminated - Clinical trials for Cellulite (Orange Peel Skin)

Safety and Efficacy of a Dietary Supplement in Females With Cellulite

Start date: May 2011
Phase: N/A
Study type: Interventional

To investigate the safety and efficacy of a dietary supplement on cellulite alleviation, fat deposits and quality of life.

NCT ID: NCT01321255 Completed - Clinical trials for Myocardial Infarction

Fixed Dose Combination Drug (Polypill)for Secondary Cardiovascular Prevention.

FOCUS
Start date: January 2012
Phase: Phase 3
Study type: Interventional

The aim of the FOCUS project is to test the Fixed Dose Combination concept for cardiovascular prevention in populations of different socio-economic characteristics. At the same time, FOCUS aims to understand the factors determining inappropriate prescribing for secondary cardiovascular prevention and those for poor patients adherence to treatment. This will allow FOCUS to establish recommendations for a better use of medication in patients with ischemic heart disease. In addition, after a successful completion of FOCUS, secondary prevention medication will be available and affordable for a large number of patients in both developed as well as developing countries. There are two Phases in this study: Phase 1: Is a descriptive, non interventional study. Phase 2: Is an interventional, randomized trial with prospective economic evaluation.

NCT ID: NCT01320917 Active, not recruiting - Obesity Clinical Trials

Levonorgestrel-releasing Intrauterine Device on Obese Women: Effects on Hemostatic and Arterial Function

Start date: February 2009
Phase: Phase 4
Study type: Interventional

Obesity is a disorder associated with metabolic dysfunction and changes in cardiovascular risk markers; the use of oral contraceptives (OCs) may exert a further negative effect on these alterations in patients with PCOS. To assess the effects on arterial function and structure and hemostatic parameters using an levonorgestrel intrauterine device (IUS-LNG) in women with obesity A randomized controlled clinical trial.

NCT ID: NCT01318941 Completed - Clinical trials for Diabetic Macular Edema

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

LUMINOUS
Start date: March 2011
Phase: N/A
Study type: Observational

This study will describe the long-term safety and effectiveness, treatment patterns,and patient reported quality of life associated with ranibizumab treatment in routine clinical practice for all approved indication included in the local product label.

NCT ID: NCT01316926 Completed - Depressive Disorder Clinical Trials

Paxil CR Bioequivalence Study Brazil

Start date: September 9, 2009
Phase: Phase 1
Study type: Interventional

The study is prospective, open, randomized, crossover in steady state and the volunteers received multiple doses of the drug test and reference (two periods of drug administration).

NCT ID: NCT01316861 Completed - Clinical trials for Type 2 Diabetes Mellitus

Efficacy and Safety of Oral Acarbose Treatment in Patients With Type 2 Diabetes Mellitus

Start date: September 2012
Phase: Phase 3
Study type: Interventional

The Purpose of This Study is to Evaluate the Efficacy and Safety of Acarbose in Type 2 Diabetic Patients Using Two Different Formulations of Acarbose 50mg.

NCT ID: NCT01316289 Completed - Clinical trials for Pilon Fracture of Tibia

Pilon Fracture Reduction and Functional Outcome

Start date: November 2011
Phase:
Study type: Observational

This prospective case series will essentially examine the influence of reduction quality on the primary functional outcome (as assessed using the FAAM) of patients with pilon fractures treated with plate fixation. The plates used in this trial can be chosen according to the preferences of the surgeon.

NCT ID: NCT01315769 Completed - Mother (Person) Clinical Trials

Pelvic Floor Muscle Function in Nulliparous and Primiparous.

Start date: March 2006
Phase: N/A
Study type: Observational

This study aimed to compare the pelvic floor muscle (PFM) strength in nulliparous and primiparous women. Subjective evaluation of PFM strength was performed vaginal digital palpation (TDP). The objective evaluation of PFM strength was assessed using a portable perineometer. All parameters were performed at one moment in G1, and in G2, during the 20th and 36th weeks of pregnancy, and 45 days after the delivery. Pregnancy and vaginal delivery may cause weakness of PFM.